BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24145652)

  • 21. The comparison of expression of cutaneous lymphocyte-associated antigen (CLA), and Th1- and Th2-associated antigens in mycosis fungoides and cutaneous lesions of adult T-cell leukemia/lymphoma.
    Yamaguchi T; Ohshima K; Tsuchiya T; Suehuji H; Karube K; Nakayama J; Suzumiya J; Yoshino T; Kikuchi M
    Eur J Dermatol; 2003; 13(6):553-9. PubMed ID: 14721775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.
    Sufficool KE; Lockwood CM; Abel HJ; Hagemann IS; Schumacher JA; Kelley TW; Duncavage EJ
    J Am Acad Dermatol; 2015 Aug; 73(2):228-36.e2. PubMed ID: 26048061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates.
    Florell SR; Cessna M; Lundell RB; Boucher KM; Bowen GM; Harris RM; Petersen MJ; Zone JJ; Tripp S; Perkins SL
    Am J Clin Pathol; 2006 May; 125(5):727-36. PubMed ID: 16707374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCR7 expression correlates with subcutaneous involvement in mycosis fungoides skin lesions and promotes migration of mycosis fungoides cells (MyLa) through mTOR activation.
    Hu SC; Lin CL; Hong CH; Yu HS; Chen GS; Lee CH
    J Dermatol Sci; 2014 Apr; 74(1):31-8. PubMed ID: 24411580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoreactivity of B-cell markers (CD79a, L26) in rare cases of extranodal cytotoxic peripheral T- (NK/T-) cell lymphomas.
    Blakolmer K; Vesely M; Kummer JA; Jurecka W; Mannhalter C; Chott A
    Mod Pathol; 2000 Jul; 13(7):766-72. PubMed ID: 10912936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The usefulness of clonality for the detection of cases clinically and/or histopathologically not recognized as cutaneous T-cell lymphoma.
    Alessi E; Coggi A; Venegoni L; Merlo V; Gianotti R
    Br J Dermatol; 2005 Aug; 153(2):368-71. PubMed ID: 16086751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cutaneous lymphoma international prognostic index (CLIPi) for mycosis fungoides and Sezary syndrome.
    Benton EC; Crichton S; Talpur R; Agar NS; Fields PA; Wedgeworth E; Mitchell TJ; Cox M; Ferreira S; Liu P; Robson A; Calonje E; Stefanato CM; Wilkins B; Scarisbrick J; Wain EM; Child F; Morris S; Duvic M; Whittaker SJ
    Eur J Cancer; 2013 Sep; 49(13):2859-68. PubMed ID: 23735705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
    Moore PF; Olivry T; Naydan D
    Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
    Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
    Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature.
    Rahemtullah A; Longtine JA; Harris NL; Dorn M; Zembowicz A; Quintanilla-Fend L; Preffer FI; Ferry JA
    Am J Surg Pathol; 2008 Nov; 32(11):1593-607. PubMed ID: 18753947
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical roundtable monograph. The management of aggressive T-cell lymphoma: a discussion on transformed mycosis fungoides.
    Horwitz SM; Duvic M; Hsi ED
    Clin Adv Hematol Oncol; 2010 Dec; 8(12):1-15. PubMed ID: 21344783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FOXP3 in sequential biopsies of progressive mycosis fungoides.
    Fried I; Cerroni L
    Am J Dermatopathol; 2012 May; 34(3):263-5. PubMed ID: 22157245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transformation of mycosis fungoides: clinicopathological and prognostic features of 45 cases. French Study Group of Cutaneious Lymphomas.
    Vergier B; de Muret A; Beylot-Barry M; Vaillant L; Ekouevi D; Chene G; Carlotti A; Franck N; Dechelotte P; Souteyrand P; Courville P; Joly P; Delaunay M; Bagot M; Grange F; Fraitag S; Bosq J; Petrella T; Durlach A; De Mascarel A; Merlio JP; Wechsler J
    Blood; 2000 Apr; 95(7):2212-8. PubMed ID: 10733487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Papular mycosis fungoides].
    Brajon D; Bonnet N; Dales JP; Berbis P
    Ann Dermatol Venereol; 2013; 140(6-7):455-8. PubMed ID: 23773745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Follicular mycosis fungoides mimicking a cutaneous B-cell lymphoproliferative disorder.
    Tan SH; Sim CS; Ong BH; Sander CA
    Australas J Dermatol; 2004 Aug; 45(3):188-91. PubMed ID: 15250902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival.
    Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E
    Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
    Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
    J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regarding the algorithm for the diagnosis of early mycosis fungoides proposed by the International Society for Cutaneous Lymphomas: suggestions from routine histopathology practice.
    Ferrara G; Di Blasi A; Zalaudek I; Argenziano G; Cerroni L
    J Cutan Pathol; 2008 Jun; 35(6):549-53. PubMed ID: 18201238
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtle CD20 positivity in the bone marrow of a patient who has a mucosa-associated lymphoid tissue lymphoma should not be regarded as evidence of involvement in the bone marrow.
    Won D; Park CJ; Shim H; Jang S; Chi HS; Huh J; Yoon DH; Suh C
    Histopathology; 2013 Feb; 62(3):397-405. PubMed ID: 23163529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.